SE8604112D0 - PHARMACEUTICAL FORMULATIONS WITH CONGTROLLED RELEASE OF THE ACTIVE SUBSTANCE - Google Patents

PHARMACEUTICAL FORMULATIONS WITH CONGTROLLED RELEASE OF THE ACTIVE SUBSTANCE

Info

Publication number
SE8604112D0
SE8604112D0 SE8604112A SE8604112A SE8604112D0 SE 8604112 D0 SE8604112 D0 SE 8604112D0 SE 8604112 A SE8604112 A SE 8604112A SE 8604112 A SE8604112 A SE 8604112A SE 8604112 D0 SE8604112 D0 SE 8604112D0
Authority
SE
Sweden
Prior art keywords
active substance
congtrolled
release
pharmaceutical formulations
pharmaceutically acceptable
Prior art date
Application number
SE8604112A
Other languages
Swedish (sv)
Other versions
SE503222C2 (en
SE8604112L (en
Inventor
O Zuger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8604112D0 publication Critical patent/SE8604112D0/en
Publication of SE8604112L publication Critical patent/SE8604112L/en
Publication of SE503222C2 publication Critical patent/SE503222C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Case 100-6717 A controlled release formulation for oral administration comprising - an active substance chosen from the group of Pindolol and a 4-(2,1, 3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester, - a pharmaceutically acceptable hydrophilic swellable substance and containing optionally a pharmaceutically acceptable inert fatty material in addition. The formulation has an excellent bioavailability and practically no food interaction after administration. 3700/KD/AB
SE8604112A 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine SE503222C2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (3)

Publication Number Publication Date
SE8604112D0 true SE8604112D0 (en) 1986-09-29
SE8604112L SE8604112L (en) 1987-04-02
SE503222C2 SE503222C2 (en) 1996-04-22

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604112A SE503222C2 (en) 1985-10-01 1986-09-29 Pharmaceutical preparations with controlled release of isradipine or darodipine

Country Status (20)

Country Link
KR (1) KR920008817B1 (en)
AT (1) AT402257B (en)
BE (1) BE905516A (en)
CA (1) CA1298784C (en)
CH (1) CH669524A5 (en)
DE (1) DE3632201C2 (en)
DK (1) DK170016B1 (en)
ES (1) ES2002508A6 (en)
FR (1) FR2589732B1 (en)
GR (1) GR862457B (en)
HK (1) HK392A (en)
HU (1) HU197201B (en)
IE (1) IE59589B1 (en)
IL (1) IL80182A (en)
LU (1) LU86615A1 (en)
NL (1) NL194822C (en)
NZ (1) NZ217732A (en)
PT (1) PT83456B (en)
SE (1) SE503222C2 (en)
SG (1) SG103391G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (en) * 2001-02-20 2008-10-15 Dinan Timothy Gerard TREATING FIBROMYALGIA WITH PINDOLOL
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (en) * 1978-12-18 1983-11-30 Sandoz Ag NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
DD145004A3 (en) * 1978-09-25 1980-11-19 Reinhard Huettenrauch METHOD FOR PRODUCING SOLID A NOMENCLATES
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (en) * 1980-05-21 1985-12-09 塩野義製薬株式会社 sustained release formulation
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (en) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd Long active tablet

Also Published As

Publication number Publication date
KR870003777A (en) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (en) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (en) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (en) 2003-04-03
IE862565L (en) 1987-04-01
DK170016B1 (en) 1995-05-01
HK392A (en) 1992-01-10
ES2002508A6 (en) 1988-08-16
FR2589732B1 (en) 1989-07-13
NZ217732A (en) 1990-07-26
DE3632201A1 (en) 1987-04-02
NL8602370A (en) 1987-05-04
FR2589732A1 (en) 1987-05-15
CA1298784C (en) 1992-04-14
SE8604112L (en) 1987-04-02
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
DK464686D0 (en) 1986-09-29
ATA260486A (en) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (en) 1987-04-02
AT402257B (en) 1997-03-25
CH669524A5 (en) 1989-03-31
PT83456B (en) 1989-05-12
DE3632201C2 (en) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (en) 2002-12-02
DK464686A (en) 1987-04-02
BE905516A (en) 1987-03-30

Similar Documents

Publication Publication Date Title
IT1200178B (en) GALENIC FORMULATIONS WITH SCHEDULED SALE CONTAINING DRUGS WITH ANTI-FLOGISTIC ACTIVITY
ES2051782T3 (en) A PHARMACEUTICAL COMPOSITION OF SLOW RELEASE.
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
DK555389D0 (en) PHARMACEUTICAL PREPARATION
ATE226815T1 (en) MANUFACTURING OF MEDICINAL PRODUCTS
DE3585107D1 (en) SOLID DRUG PREPARATIONS WITH DIHYDROPYRIDINE AND METHOD FOR THE PRODUCTION THEREOF.
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
DE68909100D1 (en) Physiologically active substances, processes for their preparation and pharmaceutical compositions thereof.
ATE243499T1 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING NIFEDIPINE AS THE ACTIVE INGREDIENT
SE8604112D0 (en) PHARMACEUTICAL FORMULATIONS WITH CONGTROLLED RELEASE OF THE ACTIVE SUBSTANCE
JPS5522631A (en) Readily absorbable nifedipine preparation
IT1204400B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN
ATE85213T1 (en) A MEDICINAL PRODUCT CONTAINING AN ACTIVE SUBSTANCE AND A WATER-SWELLING POLYMER.
IT8722501A0 (en) PHARMACEUTICAL FORMULATIONS FOR TRANSDERMAL ADMINISTRATION.
KR890701087A (en) Formulation for oral administration of buspirone and its salts
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
JPS57167911A (en) Liquid pharmaceutical of nifedipine
ATE227123T1 (en) TRANSDERMAL PATCH CONTAINING SOLID METHYLPHENIDATE
DE69209916D1 (en) Oral medicinal product containing dapiprazole
IT1214719B (en) Controlled release cardiovascular preparations
ATE212840T1 (en) SOLID MEDICINAL PREPARATIONS FOR ORAL APPLICATION WITH MODULATED RELEASE OF ACTIVE INGREDIENTS CONTAINING NICORANDIL AND METHOD FOR THE PRODUCTION THEREOF
EP0367509A3 (en) Formulations
ATE15139T1 (en) PHOSPHONOMYCINE PHARMACEUTICAL COMPOSITION IN TABLET FORM.
IT1225460B (en) PHARMACEUTICAL TABLETS WITH CONTROLLED RELEASE CONSISTING OF MIXTURES OF SCLEROGLUCAN AND ACTIVE SUBSTANCE.
MY102906A (en) Pharmaceutical 9, 10-dihydro ergot alkaloid containing compositions

Legal Events

Date Code Title Description
NUG Patent has lapsed